Is angelinipharma.sk Safe? Security Analysis for Angelini Pharma Slovenská republika, s.r.o.
https://angelinipharma.skCheck if angelinipharma.sk is a scam or legitimate. Free security scan and reviews.
Above Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for angelinipharma.sk
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Angelini Pharma Slovenská republika, s.r.o. operates a professional pharmaceutical website focused on central nervous system (CNS) disorders, pain management, rare diseases, and consumer health products. The company is positioned as a leading player in these sectors within Slovakia and broader European markets, supported by its parent company Angelini S.p.a. The website provides comprehensive corporate information, research and development insights, and product details tailored to healthcare professionals and consumers. The presence of multiple country-specific Angelini Pharma domains indicates a broad regional footprint. Technically, the website employs modern JavaScript libraries such as jQuery, Slick Carousel, and Magnific Popup, alongside privacy-focused analytics via Piwik PRO. The site is well-optimized for mobile devices and demonstrates good SEO practices. Hosting and resource domains are consistent with the Angelini corporate group, and asynchronous script loading supports moderate performance. From a security perspective, the site enforces HTTPS and implements cookie consent mechanisms aligned with GDPR requirements. However, explicit security headers and published security policies or incident response information are absent, representing areas for improvement. No vulnerabilities or exposed sensitive data were detected in the HTML content. The WHOIS data indicates privacy protection for domain registration, which is justified for this business type and does not raise legitimacy concerns. Overall, the website is professional, trustworthy, and compliant with privacy regulations, though it could enhance its security posture by publishing explicit policies and improving header configurations. The lack of direct contact emails or phone numbers on the site is noted but does not significantly detract from credibility given the corporate nature and presence of physical address and social media channels.
Detected Technologies
8 urgent findings need attention
8 high
Keep angelinipharma.sk under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
2 findings
90/100
GDPR Compliance
2 findings
73/100
NIS2 Compliance
9 findings
2/100
Email Security
2 findings
65/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Angelini Pharma is a medium-sized pharmaceutical company operating in Slovakia under the umbrella of Angelini S.p.a. Its market positioning is strong in CNS, pain, rare diseases, and consumer health sectors. The business model focuses on research, development, manufacturing, and distribution of pharmaceutical products. The company targets healthcare professionals and patients, emphasizing holistic patient care. The website reflects a mature digital presence with multiple country-specific subsidiaries, indicating a well-established partnership ecosystem and regional market penetration. Trust indicators such as the Top Employer Europe 2025 certification and comprehensive privacy compliance support a credible brand image. Growth potential is supported by active research collaborations and product pipeline development.
Extracted Contact Information
Marketing Intelligence Data
Physical Addresses (1)
Company Registration
Angelini Pharma Slovenská republika, s.r.o.
48116351
Security Posture Analysis
Comprehensive Security Assessment
The website demonstrates a moderate to good security maturity level. HTTPS is enforced, and cookie consent mechanisms are implemented using Piwik PRO, which respects user privacy. However, the absence of explicit security headers such as Content Security Policy (CSP), HSTS, and X-Frame-Options reduces the overall security posture. No security or incident response policies are published, and no vulnerability disclosure or security.txt files are present, limiting transparency in security management. No exposed sensitive data or vulnerable libraries were detected. The site would benefit from publishing security policies, adding security headers, and providing clear incident response contacts to enhance trust and compliance with best practices.
Strategic Recommendations
Priority Actions for Security Improvement
Implement and publish explicit security headers including CSP, HSTS, X-Frame-Options, and X-XSS-Protection.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Angelini Pharma Slovenská republika, s.r.o.
Angelini Pharma sa zameriava na oblast centrálneho nervového systému (CNS), vrátane bolesti a zriedkavých ochorení. Spoločnosť je tiež popredným hráčom v sektore Consumer Health.
good
consistent
Technical Stack
moderate
good
basic
good
Security Assessment
- HTTPS enforced
- Cookie consent mechanism implemented
- No exposed sensitive data in HTML
- Use of Piwik PRO for privacy-focused analytics
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is fully accessible with no blocking or WAF challenges.
Get this report delivered to your inbox
Receive a summary of the angelinipharma.sk security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Weak Referrer-Policy configuration
LOWCurrent value: "no-referrer-when-downgrade"
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Critical sector without clear security compliance
HIGHDetected sectors: energy, transport, health, digital
Need this report as a PDF?
Download the complete angelinipharma.sk security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No DMARC record found
HIGHDMARC provides email authentication and reporting
No DKIM record found
MEDIUMDKIM adds cryptographic signatures to emails
SPF Details
DMARC Details
MTA-STS Details
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 59 days
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
Domain Transfer Lock Not Enabled
MEDIUMDomain can be transferred without authorization
Domain Delete Lock Not Enabled
LOWDomain can be deleted without additional verification
Domain Registration Details
- •No domain protection locks enabled
DNS Records
DNSSEC Status
DNS Performance
SPF Analysis
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does angelinipharma.sk compare?
See how angelinipharma.sk stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the angelinipharma.sk report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the angelinipharma.sk report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about angelinipharma.sk
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published